Search
Search
Close this search box.

Ohio’s Fledgling Adult-Use Cannabis Market Surpasses Sales of $87m, Shows No Signs of Slowing

Ohio’s adult-use cannabis market, which was launched just two months ago, has already exceeded $87m in sales.

According to the latest statistics from the Ohio Division of Cannabis Control (DCC), since the launch of its adult-use market on August 06, sales have continued to increase, topping $43.07m in September alone, averaging around $1.5m per day.

The state has now issued 124 ‘dual-use’ licenses, which enable dispensaries to sell both medical and adult-use cannabis, and since launch these have sold more than 10,000 pounds of plant material and over 1.3 million units of manufactured cannabis products.

While Ohio still represents one of the most expensive states to purchase cannabis, especially compared to neighbouring states with more mature markets like Michigan, costs are gradually declining as accessibility increases.

In September, the cost per one-tenth ounce of flower fell from $24.24 to $23.74, while the average price per gram dropped from $8.57 to $8.39.

Over 100 smaller municipalities in Ohio have opted to prevent the launch of adult-use sales, meaning dispensaries are concentrated in major cities.

Despite these limitations, Ohio’s strategy of enabling existing medical cannabis businesses to expand into adult-use sales mean the state has not suffered from the early supply chain issues many other states have suffered from.

According to market analysis from Headset, the state’s cannabis market could reach $2.1 billion annually at full maturity.

⏰ Pre-order discount ends Jan 15
-- Days
-- Hours
-- Mins
Data packs delivered January 2026
🔬 New Report Due January 2026

Global Medical Cannabis Market Review 2026

A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.

What's covered

  • 📊 Global supply chain overview — understand export/import dynamics and domestic production capabilities
  • 🌍 8 export country snapshots — Canada, Portugal, Denmark, North Macedonia, Spain, Australia, Czech Republic, South Africa
  • 👥 6 patient market snapshots — Australia, Germany, UK, Poland, Brazil, France
  • 🔮 Key themes — Canada's global impact, telemedicine growth, new market openings, quota changes
Export Markets
🇨🇦 Canada 🇵🇹 Portugal 🇩🇰 Denmark 🇲🇰 N. Macedonia 🇪🇸 Spain 🇦🇺 Australia 🇨🇿 Czechia 🇿🇦 South Africa
Patient Markets
🇦🇺 Australia 🇩🇪 Germany 🇬🇧 UK 🇵🇱 Poland 🇧🇷 Brazil 🇫🇷 France
100% free • No credit card required
As trusted by
DIAGEO KPMG Coca-Cola BARCLAYS BNP PARIBAS AB InBev NOVARTIS Johnson & Johnson PEPSICO AXA POLITICO Bloomberg amazon CNN Business
Part of our annual market review series GDPR compliant

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?